Daiwa Securities Group’s Cellectis CLLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-40
Closed 1328
2022
Q3
$0 Hold
40
﹤0.01% 1348
2022
Q2
$0 Hold
40
﹤0.01% 1370
2022
Q1
$0 Hold
40
﹤0.01% 1382
2021
Q4
$0 Hold
40
﹤0.01% 1400
2021
Q3
$1K Hold
40
﹤0.01% 1265
2021
Q2
$1K Hold
40
﹤0.01% 1184
2021
Q1
$1K Hold
40
﹤0.01% 1190
2020
Q4
$1K Sell
40
-60
-60% -$1.35K ﹤0.01% 1168
2020
Q3
$2K Hold
100
﹤0.01% 1138
2020
Q2
$1K Hold
100
﹤0.01% 1181
2020
Q1
$1K Hold
100
﹤0.01% 1184
2019
Q4
$2K Hold
100
﹤0.01% 1157
2019
Q3
$1K Hold
100
﹤0.01% 1148
2019
Q2
$2K Hold
100
﹤0.01% 1145
2019
Q1
$2K Buy
100
+51
+104% +$904 ﹤0.01% 1126
2018
Q4
$1K Hold
49
﹤0.01% 1126
2018
Q3
$1K Hold
49
﹤0.01% 1145
2018
Q2
$1K Hold
49
﹤0.01% 1162
2018
Q1
$2K Buy
+49
New +$1.55K ﹤0.01% 1122

Other funds holding CLLS

Daiwa Securities Group's CLLS Position: Q4 2022 in Review

Daiwa Securities Group sold out of Cellectis (CLLS) in Q4 2022, closing a stake of 40 shares.

Daiwa Securities Group first reported a position in CLLS in Q1 2018 and held it in 19 quarters. The position peaked at $2K in Q3 2020. 40 funds tracked by Wall St. Rank hold CLLS as of Q4 2022.

  • Daiwa Securities Group reported no remaining Cellectis position as of Q4 2022 after selling out during the quarter.
  • Daiwa Securities Group sold 40 Cellectis shares in Q4 2022.
  • Daiwa Securities Group first reported a position in Cellectis in Q1 2018 and held it in 19 quarters.
  • Daiwa Securities Group's Cellectis position peaked at $2K in Q3 2020.
  • 40 funds tracked by Wall St. Rank held Cellectis as of Q4 2022.

Based on Daiwa Securities Group's 13F filing for Q4 2022, filed 6 Feb 2023.